X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (411) 411
Patent (250) 250
Publication (101) 101
Conference Proceeding (4) 4
Newspaper Article (4) 4
Dissertation (2) 2
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (263) 263
chemistry (241) 241
metallurgy (241) 241
biochemistry (235) 235
human necessities (233) 233
hygiene (232) 232
medical or veterinary science (232) 232
peptides (228) 228
preparations for medical, dental, or toilet purposes (228) 228
beer (226) 226
enzymology (226) 226
mutation or genetic engineering (226) 226
spirits (226) 226
vinegar (226) 226
wine (226) 226
compositions thereof (225) 225
culture media (225) 225
microorganisms or enzymes (225) 225
propagating, preserving or maintaining microorganisms (225) 225
organic chemistry (215) 215
humans (203) 203
index medicus (135) 135
virology (123) 123
hiv-1 - genetics (113) 113
hiv-1 - immunology (113) 113
viruses (102) 102
hiv (96) 96
immunology (84) 84
molecular sequence data (82) 82
phylogeny (77) 77
hiv infections - immunology (76) 76
amino acid sequence (74) 74
animals (70) 70
specific therapeutic activity of chemical compounds ormedicinal preparations (65) 65
vaccines (64) 64
hiv infections - virology (63) 63
human-immunodeficiency-virus (61) 61
aids (58) 58
female (57) 57
infection (56) 56
infectious diseases (56) 56
hiv-1 - classification (54) 54
aids vaccines - immunology (53) 53
article (51) 51
male (49) 49
human immunodeficiency virus--hiv (47) 47
nucleic acids (46) 46
nucleosides (46) 46
derivatives thereof (45) 45
nucleotides (45) 45
sugars (45) 45
mutation (44) 44
research (44) 44
infections (42) 42
antibodies (41) 41
genetic variation (41) 41
hiv-1 (41) 41
virus diseases (41) 41
biology (39) 39
health aspects (39) 39
hiv antibodies - immunology (39) 39
evolution, molecular (38) 38
evolution (37) 37
immunodeficiency-virus type-1 (37) 37
multidisciplinary sciences (37) 37
research article (35) 35
aids vaccines (33) 33
human immunodeficiency virus (33) 33
viral load (32) 32
hiv envelope protein gp120 - immunology (30) 30
antibodies, neutralizing - immunology (29) 29
acquired immune deficiency syndrome--aids (28) 28
epitopes (28) 28
epitopes, t-lymphocyte - immunology (28) 28
hiv infection (28) 28
neutralization tests (28) 28
base sequence (27) 27
immune-responses (27) 27
medical research (27) 27
rhesus-monkeys (27) 27
adult (25) 25
neutralizing antibodies (25) 25
proteins (25) 25
env gene products, human immunodeficiency virus - immunology (24) 24
epitopes - immunology (24) 24
hiv infections - transmission (24) 24
t-lymphocytes, cytotoxic - immunology (24) 24
vaccination (24) 24
acquired immune deficiency syndrome (23) 23
genetic aspects (23) 23
immune response (23) 23
t cells (23) 23
cd8-positive t-lymphocytes - immunology (22) 22
diversity (22) 22
in-vivo (22) 22
sequence alignment (22) 22
vaccine (22) 22
analysis (21) 21
hiv envelope protein gp120 - genetics (21) 21
hiv infections - prevention & control (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (641) 641
French (118) 118
German (65) 65
Chinese (7) 7
Japanese (4) 4
Portuguese (4) 4
Hebrew (2) 2
Korean (2) 2
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Polish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Liao, Hua-Xin and Lynch, Rebecca and Zhou, Tongqing and Gao, Feng and Munir Alam, S and Boyd, Scott D and Fire, Andrew Z and Roskin, Krishna M and Schramm, Chaim A and Zhang, Zhenhai and Zhu, Jiang and Shapiro, Lawrence and Mullikin, James C and Gnanakaran, S and Hraber, Peter and Wiehe, Kevin and Kelsoe, Garnett and Yang, Guang and Xia, Shi-Mao and Montefiori, David C and Parks, Robert and Lloyd, Krissey E and Scearce, Richard M and Soderberg, Kelly A and Cohen, Myron and Kamanga, Gift and Louder, Mark K and Tran, Lillian M and Chen, Yue and Cai, Fangping and Chen, Sheri and Moquin, Stephanie and Du, Xiulian and Gordon Joyce, M and Srivatsan, Sanjay and Zhang, Baoshan and Zheng, Anqi and Shaw, George M and Hahn, Beatrice H and Kepler, Thomas B and Korber, Bette T. M and Kwong, Peter D and Mascola, John R and Haynes, Barton F and Becker, Jesse and Benjamin, Betty and Blakesley, Robert and Bouffard, Gerry and Brooks, Shelise and Coleman, Holly and Dekhtyar, Mila and Gregory, Michael and Guan, Xiaobin and Gupta, Jyoti and Han, Joel and Hargrove, April and Ho, Shi-Ling and Johnson, Taccara and Legaspi, Richelle and Lovett, Sean and Maduro, Quino and Masiello, Cathy and Maskeri, Baishali and McDowell, Jenny and Montemayor, Casandra and Mulliki, James and Park, Morgan and Riebow, Nancy and Schandler, Karen and Schmidt, Brian and Sison, Christina and Stantripop, Mal and Thomas, James and Thomas, Pam and Vemulapalli, Meg and Young, Alice and NISC Comparative Sequencing Progra and NISC Comparative Sequencing Program
Nature, ISSN 0028-0836, 04/2013, Volume 496, Issue 7446, pp. 469 - 476
Current human immunodeficiency virus-1 (HIV-1) vaccines elicit strain-specific neutralizing antibodies. However, cross-reactive neutralizing antibodies arise... 
CRYSTALLIZATION | B-CELL RESPONSES | CONFORMATIONAL EPITOPE | POTENT NEUTRALIZATION | EVOLUTION | CD4 BINDING-SITE | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | HUMAN MONOCLONAL-ANTIBODIES | SUBTYPE-B | IN-SITU PROTEOLYSIS | HIV Envelope Protein gp120 - genetics | Clone Cells - cytology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Crystallography, X-Ray | Neutralization Tests | Phylogeny | HIV Envelope Protein gp120 - metabolism | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | HIV Envelope Protein gp120 - chemistry | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Protein Structure, Tertiary | Amino Acid Sequence | CD4 Antigens - immunology | Africa | Cells, Cultured | Models, Molecular | Antibodies, Neutralizing - genetics | Cross Reactions - immunology | HIV Antibodies - chemistry | HIV-1 - classification | Antibodies, Monoclonal - genetics | Cell Lineage | HIV-1 - immunology | CD4 Antigens - chemistry | Antibodies, Neutralizing - chemistry | Epitopes - chemistry | HIV Antibodies - genetics | Mutation | Evolution, Molecular | Monoclonal antibodies | AIDS vaccines | Genetic aspects | Research | HIV (Viruses) | Properties | Proteins | Plasma | Infections | Patients | Binding sites | Crystal structure
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 6, p. e20479
T cell directed HIV vaccines are based upon the induction of CD8+ T cell memory responses that would be effective in inhibiting infection and subsequent... 
IMMUNOGENICITY | MEDIATED-IMMUNITY | VIRUS | CLINICAL-TRIAL | DNA VACCINE | SAFETY | ENHANCED DETECTION | REVERSE-TRANSCRIPTASE | BIOLOGY | CLADE | SITE-DIRECTED MUTAGENESIS | Amino Acid Sequence | Epitope Mapping | Human Immunodeficiency Virus Proteins - immunology | Bias | Humans | AIDS Vaccines - immunology | Male | Treatment Outcome | Epitopes, T-Lymphocyte - chemistry | HIV Infections - immunology | HIV-1 - immunology | Human Immunodeficiency Virus Proteins - chemistry | HIV Infections - therapy | Adult | Female | T-Lymphocytes - immunology | Conserved Sequence - immunology | Epitopes, T-Lymphocyte - immunology | Clinical Trials, Phase I as Topic | Medical research | AIDS vaccines | Peptides | Vaccination | Genomics | Amino acids | T cells | HIV (Viruses) | Infection | Medicine, Experimental | Comparative analysis | Health aspects | Antigenic determinants | Laboratories | CD8 antigen | Cytotoxicity | Viruses | Genomes | Lymphocytes T | Infections | Vaccines | Gag protein | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Masking | Sampling | Enzyme-linked immunosorbent assay | Immunological memory | Immunosurveillance | Nef protein | Immunogenicity | Frequency analysis | Replication | Adults | Gene mapping | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 08/2015, Volume 11, Issue 8, p. e1005042
Journal Article
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 10/2019, pp. 1 - 10
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e75665
Neutralizing and non-neutralizing antibodies to linear epitopes on HIV-1 envelope glycoproteins have potential to mediate antiviral effector functions that... 
DEPENDENT CELLULAR CYTOTOXICITY | RECOMBINANT GLYCOPROTEIN-120 VACCINE | CONFORMATIONAL EPITOPE | NEUTRALIZING ANTIBODIES | BROAD NEUTRALIZATION | CD4 BINDING-SITE | MULTIDISCIPLINARY SCIENCES | ENVELOPE PROTEIN | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | TRANSMEMBRANE PROTEIN | HIV Antibodies - blood | HIV Envelope Protein gp120 - genetics | HIV Infections - prevention & control | Immunoglobulin G - blood | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Risk | Case-Control Studies | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | HIV Infections - blood | Amino Acid Sequence | HIV-1 - genetics | Antigens, Viral - immunology | HIV-1 - immunology | Sequence Alignment | B-Lymphocytes - immunology | Immunoglobulin A - immunology | Antibodies, Neutralizing - blood | Medical research | Medical colleges | AIDS vaccines | Peptides | Immunoglobulin G | Clinical trials | Glycoproteins | HIV (Viruses) | Risk factors | Infection | Medicine, Experimental | Health aspects | Antigenic determinants | Correlation | Laboratories | Antibodies | Viruses | Cytotoxicity | Biology | Infections | Vaccines | Immunoglobulin A | Human immunodeficiency virus--HIV | Public health | Recombinant | Antigens | Immunoglobulins | Immune response | Effectiveness | Glycoprotein gp41 | Research & development--R&D | Health risks | Risk reduction | Epitopes | Biophysics | Glycoprotein gp160 | Infectious diseases | Lymphocytes B | Neutralizing | Glycoprotein gp120 | Cancer | Research & development | R&D | HIV | Human immunodeficiency virus
Journal Article